Brivaracetam versus levetiracetam for epilepsy a review of comparative clinical safety
The purpose of this report is to summarize the evidence regarding the comparative clinical safety of BRV compared to LEV among patients with epilepsy with mental health conditions as well as in patients with epilepsy who experienced psychiatric or behavioral adverse events with previous LEV treatmen...
Main Authors: | , |
---|---|
Corporate Author: | |
Format: | eBook |
Language: | English |
Published: |
Ottawa
Canadian Agency for Drugs and Technologies in Health
2020, December 1, 2020
|
Edition: | Version:1.0 |
Series: | CADTH rapid response report: summary with critical appraisal
|
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The purpose of this report is to summarize the evidence regarding the comparative clinical safety of BRV compared to LEV among patients with epilepsy with mental health conditions as well as in patients with epilepsy who experienced psychiatric or behavioral adverse events with previous LEV treatment |
---|---|
Physical Description: | 1 PDF file (35 pages) illustration |